A position paper for the diagnosis and management of infections caused by multidrug-resistant bacteria

  24 June 2022

Management of patients with infections caused by multidrug resistant organisms is challenging and requires a multidisciplinary approach to achieve successful clinical outcomes. The aim of this position paper is to provide recommendations for the diagnosis and the optimal management of these infections, with a focus on targeted antibiotic therapy.

The document was produced by a panel of experts nominated by the five endorsing Italian societies: the Italian Association of Clinical Microbiologists (AMCLI), the Italian Group for Antimicrobial Stewardship (GISA), Italian Society of Microbiology (SIM), the Italian Society of Infectious and Tropical Diseases (SIMIT), and the Italian Society of Anti-Infective Therapy (SITA). PICO questions about microbiological diagnosis, pharmacological strategies, and targeted antibiotic therapy were addressed for the pathogens: carbapenem-resistant Enterobacterales, carbapenem-resistant Pseudomonas aeruginosa, carbapenem-resistant Acinetobacter baumannii and methicillin-resistant Staphylococcus aureus.

Author(s): Giusy Tiseo et al
Effective Surveillance  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

Antimicrobial Resistance Fighter Coalition

Evotec

JSS University





Technology Database

Display your AMR Technology, Product and Service

Suppliers and Users of Technologies, Products and Services benefit from CAPI.
CAPI (Continuous AMR Partnering Initiative) unites Suppliers and Users worldwide with the aim to add to the curbing of AMR.

Read more and make your own Technology Page >>
What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!